Pre-order Enquiry
Request Free Sample
Global Pneumonia Therapeutics Market 2017-2021
SKU ID : TNV-11459512 | Publishing Date : 22-Nov-2017 | No. of pages : 87
About Pneumonia Therapeutics
Pneumonia is a respiratory disease characterized by inflammation of air sacs in lungs due to bacterial or viral infection. Pneumonia therapeutics market encompasses drugs and vaccines used for the treatment of pneumonia along with oxygen therapy. The global pneumonia therapeutics market is an important part of the global respiratory disorder drugs market. The treatment of pneumonia involves three major categories, namely, vaccines, drugs, and oxygen therapy. Oxygen therapy is often used as a supplement to other therapies when the patient faces difficulty in breathing.
Technavio’s analysts forecast the global pneumonia therapeutics market to grow at a CAGR of 6.66% during the period 2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global pneumonia therapeutics market for 2017-2021 . To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Pneumonia Therapeutics Market 2017-2021 , has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• GlaxoSmithKline
• Merck Sharp & Dohme
• Novartis
• Pfizer
Other prominent vendors
• AstraZeneca
• Bayer
• Biotest
• Ono Pharmaceutical
• Tetraphase Pharmaceuticals
Market driver
• Increased awareness about prophylaxis by vaccines
• For a full, detailed list, view our report
Market challenge
• New strains of MDR bacteria
• For a full, detailed list, view our report
Market trend
• Strong pipeline
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Pneumonia is a respiratory disease characterized by inflammation of air sacs in lungs due to bacterial or viral infection. Pneumonia therapeutics market encompasses drugs and vaccines used for the treatment of pneumonia along with oxygen therapy. The global pneumonia therapeutics market is an important part of the global respiratory disorder drugs market. The treatment of pneumonia involves three major categories, namely, vaccines, drugs, and oxygen therapy. Oxygen therapy is often used as a supplement to other therapies when the patient faces difficulty in breathing.
Technavio’s analysts forecast the global pneumonia therapeutics market to grow at a CAGR of 6.66% during the period 2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global pneumonia therapeutics market for 2017-2021 . To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Pneumonia Therapeutics Market 2017-2021 , has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• GlaxoSmithKline
• Merck Sharp & Dohme
• Novartis
• Pfizer
Other prominent vendors
• AstraZeneca
• Bayer
• Biotest
• Ono Pharmaceutical
• Tetraphase Pharmaceuticals
Market driver
• Increased awareness about prophylaxis by vaccines
• For a full, detailed list, view our report
Market challenge
• New strains of MDR bacteria
• For a full, detailed list, view our report
Market trend
• Strong pipeline
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
